Health Care & Life Sciences » Biotechnology | LG Life Sciences Ltd.

LG Life Sciences Ltd. Pfd. Series 1 | Ownership

Companies that own LG Life Sciences Ltd. Pfd. Series 1

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Matthews International Capital Management LLC
1,007,286
13.1%
1,621
0.56%
06/30/2018
Schroder Investment Management Ltd.
324,671
4.22%
-12,569
0.04%
05/31/2018
Skagen AS (Investment Management)
259,179
3.37%
0
0.65%
06/30/2018
Nordea Investment Management AB (Denmark)
244,244
3.18%
5,383
0.06%
05/31/2018
The Vanguard Group, Inc.
187,645
2.44%
-3,037
0%
07/31/2018
Eastspring Investments (Singapore) Ltd.
183,894
2.39%
280
0.14%
04/16/2018
BlackRock Fund Advisors
175,444
2.27%
2
0%
09/06/2018
Candriam Belgium SA
107,986
1.4%
0
0.09%
07/31/2018
C WorldWide Asset Management Fondsmæglerselskab A/S
74,887
0.97%
1,045
0.13%
08/31/2018
Symphonia SGR SpA
61,060
0.79%
25,858
1.14%
03/29/2018

About LG Life Sciences

View Profile
Address
LG Twin Tower
Seoul SL 07336
Korea, Republic Of
Employees -
Website http://www.lgchem.com
Updated 09/14/2018
LG Chem Ltd. manufactures petrochemicals, IT & electronic materials and energy solution materials. It operates through through the following business segments: Petrochemicals, IT & Electronic Materials, Batteries. The Petrochemical division offers naphtha cracking centers and polyolefins, synthetic rubbers and specialty polymers, polyvinyl chloride, acrylonitrile-butadiene-styrene and engineering plastics, acrylates and plasticizers.